Gerhard Domagk
- Co-authors
- Werner SiefkenSven PetersenC.‐W. SchellhammerSteffen E. PetersenE. TietzeSiegfried Petersen
- Topics
- Tuberculosis Research and Epidemiology (12 papers)Mycobacterium research and diagnosis (7 papers)Diagnosis and treatment of tuberculosis (5 papers)
- Cited by
- ToxicologyOrganic ChemistryOncology
- Journals
- Clinical Infectious DiseasesAnnals of the New York Academy of SciencesJournal of Molecular Medicine
- Partner nations
- Germany
In The Last Decade
Gerhard Domagk
30 papers receiving 242 citations
Peers
Comparison fields: 5 of 69
- Organic Chemistry 122
- Molecular Biology 86
- Oncology 50
- Epidemiology 35
- Infectious Diseases 32
Countries citing papers authored by Gerhard Domagk
This map shows the geographic impact of Gerhard Domagk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Domagk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Domagk more than expected).
Fields of papers citing papers by Gerhard Domagk
This network shows the impact of papers produced by Gerhard Domagk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Domagk. The network helps show where Gerhard Domagk may publish in the future.
Co-authorship network of co-authors of Gerhard Domagk
This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Domagk. A scholar is included among the top collaborators of Gerhard Domagk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Domagk. Gerhard Domagk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | Bacterial Resistance and Chemotherapy in Tuberculosis. | 1 |
| 4 | [Status and prospects of chemotherapy in tuberculosis. Has other chemotherapy become necessary because of change in type and change in resistance of tubercle bacilli?]. | 1 |
| 5 | [Tubercle bacillus resistance and chemotherapy in tuberculosis]. | 1 |
| 6 | [Current indications for the chemotherapy of malignant tumors with ethyleneiminobenzoquinones]. | 1 |
| 7 | 7 | |
| 8 | 6 | |
| 9 | [Development of chemotherapy in the past 25 years and the prospect of the future]. | 2 |
| 10 | 5 | |
| 11 | 14 | |
| 12 | 14 | |
| 13 | 37 | |
| 14 | 5 | |
| 15 | 42 | |
| 16 | [Therapy of experimental tuberculosis with neoteben]. | 2 |
| 17 | 3 | |
| 18 | 32 | |
| 19 | 33 | |
| 20 | [Chemotherapy of acute bacterial infections and tuberculosis]. | 0 |
About Gerhard Domagk
Gerhard Domagk is a scholar working on Infectious Diseases, Toxicology and Pharmaceutical Science, having authored 35 papers that have together received 278 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (7 papers) and Diagnosis and treatment of tuberculosis (5 papers). The work is most often cited by research in Toxicology (16 citations), Organic Chemistry (122 citations) and Oncology (50 citations). Gerhard Domagk has collaborated with scholars based in Germany. Frequent co-authors include Werner Siefken, Sven Petersen, C.‐W. Schellhammer, Steffen E. Petersen, E. Tietze and Siegfried Petersen. Their work appears in journals such as Clinical Infectious Diseases, Annals of the New York Academy of Sciences and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.